fluorodopa f 18 has been researched along with Central Nervous System Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, G; Guedj, E; Kaphan, E; Molines, E; Salgues, B | 1 |
| Gesuwan, K; Herscovitch, P; Kebebew, E; Kitano, M; Linehan, WM; Millo, C; Nilubol, N; Weisbrod, AB | 1 |
2 other study(ies) available for fluorodopa f 18 and Central Nervous System Neoplasm
| Article | Year |
|---|---|
High 18F-FDOPA PET Uptake in Primary Central Nervous System Lymphoma.
Topics: Adult; Biological Transport; Central Nervous System Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Lymphoma, Non-Hodgkin; Male; Positron-Emission Tomography | 2021 |
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
Topics: Adult; Central Nervous System Neoplasms; Cohort Studies; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Kidney Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Prospective Studies; von Hippel-Lindau Disease | 2012 |